Rigel Pharmaceuticals, Inc. - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360° view of the company.
Features:
- Detailed information on Rigel Pharmaceuticals, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Rigel Pharmaceuticals, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Rigel Pharmaceuticals, Inc. including a breakdown and examination of key business segments
- Intelligence on Rigel Pharmaceuticals, Inc.'s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Rigel Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trendsRigel Pharmaceuticals (Rigel) is a clinical stage drug development company engaged in the discovery and development of small-molecule drugs for the treatment of inflammatory and autoimmune disorders, and muscle and metabolic diseases. The company operates in the US. It is headquartered in South San Francisco, California and employed 145 people as of December 2010. The company recorded revenues of $125 million during the financial year ended December 2010 (FY2010), as compared to revenues of $0.8 million in FY2009. The operating profit of the company was $35.3 million during FY2010, as compared to operating loss of $112 million in FY2009. The net profit was $37.9 million in FY2010, as compared to net loss of $111.5 million in FY2009.
Reasons to Purchase:
- Gain understanding of Rigel Pharmaceuticals, Inc. and the factors that influence its strategies
- Track strategic initiatives of the company and latest corporate news and actions
- Assess Rigel Pharmaceuticals, Inc. as a prospective partner, vendor or supplier
- Support sales activities by understanding your customers' businesses better
- Stay up to date on Rigel Pharmaceuticals, Inc.'s business structure, strategy and prospects
Click for Report details:Rigel Pharmaceuticals, Inc. - Strategy and SWOT Report
